StockData
INSMED Inc logo

INSMED Inc (INSM) stock

INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/30131% above fair value
$141.33−3.13 (-2.17%)

Close on Nov 20, 2026Market cap $31.01BP/E –Yield –

Insmed gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Insmed's gross profit for the twelve months ending Sep 30, 2026 was $1.28B, up 274.9% year over year. For fiscal 2025 it was $483.49M, up 73.9% from the year before. The highest annual figure on record is $483.49M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$483.49M+73.9%
FY2024Dec 31, 2024$277.97M+16.0%
FY2023Dec 31, 2023$239.64M+26.0%
FY2022Dec 31, 2022$190.23M+31.8%
FY2021Dec 31, 2021$144.31M+15.9%
FY2020Dec 31, 2020$124.54M+10.9%
FY2019Dec 31, 2019$112.26M+1414.5%
FY2018Dec 31, 2018$7.41M–
FY2017Dec 31, 2017$0–
FY2016Dec 31, 2016$0–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$446.21M+295.0%
Q2 FY2026Jun 30, 2026$358.27M+351.6%
Q1 FY2026Mar 31, 2026$258.54M+261.4%
Q4 FY2025Dec 31, 2025$219.62M+180.5%
Q3 FY2025Sep 30, 2025$112.98M+56.4%
Q2 FY2025Jun 30, 2025$79.34M+14.4%
Q1 FY2025Mar 31, 2025$71.55M+23.3%
Q4 FY2024Dec 31, 2024$78.29M+20.0%
Q3 FY2024Sep 30, 2024$72.26M+15.9%
Q2 FY2024Jun 30, 2024$69.38M+14.4%
Q1 FY2024Mar 31, 2024$58.04M+13.0%
Q4 FY2023Dec 31, 2023$65.25M+41.1%
Q3 FY2023Sep 30, 2023$62.37M+14.9%
Q2 FY2023Jun 30, 2023$60.64M+24.2%
Q1 FY2023Mar 31, 2023$51.38M+25.6%
Q4 FY2022Dec 31, 2022$46.23M+7.9%
Q3 FY2022Sep 30, 2022$54.26M+48.4%
Q2 FY2022Jun 30, 2022$48.83M+41.4%
Q1 FY2022Mar 31, 2022$40.92M+34.7%
Q4 FY2021Dec 31, 2021$42.84M+40.2%
Q3 FY2021Sep 30, 2021$36.57M+10.8%
Q2 FY2021Jun 30, 2021$34.53M+6.1%
Q1 FY2021Mar 31, 2021$30.37M+6.9%
Q4 FY2020Dec 31, 2020$30.55M-17.4%
Q3 FY2020Sep 30, 2020$33.02M+1.8%
Q2 FY2020Jun 30, 2020$32.55M+29.9%
Q1 FY2020Mar 31, 2020$28.42M+60.1%
Q4 FY2019Dec 31, 2019$37.00M+399.2%
Q3 FY2019Sep 30, 2019$32.45M–
Q2 FY2019Jun 30, 2019$25.05M–
Q1 FY2019Mar 31, 2019$17.75M–
Q4 FY2018Dec 31, 2018$7.41M–
Q3 FY2018Sep 30, 2018$0–
Q2 FY2018Jun 30, 2018$0–
Q1 FY2018Mar 31, 2018$0–
Q4 FY2017Dec 31, 2017$0–
Q3 FY2017Sep 30, 2017$0–
Q2 FY2017Jun 30, 2017$0–
Q1 FY2017Mar 31, 2017$0–

More Insmed figures

See a number that looks wrong?